Cargando…
Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer
Lung cancer is the leading cause of cancer death in the United States and five-year survival remains low. Numerous studies have shown that chronic inflammation may lead to progression of carcinogenesis. As a result of inflammatory stimulation, arachidonic acid (AA) metabolism produces proliferation...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652614/ https://www.ncbi.nlm.nih.gov/pubmed/19277204 http://dx.doi.org/10.1155/2008/750238 |